CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-09 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +9,143 | $16.20 | $148K | 9,441,725 |
| 2017-01-09 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +1,602 | $15.13 | $24K | 1,137,167 |
| 2017-01-09 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +15,148 | $15.13 | $229K | 9,456,873 |
| 2017-01-09 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +529 | $15.62 | $8K | 1,137,696 |
| 2017-01-09 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +5,006 | $15.62 | $78K | 9,461,879 |
| 2017-01-09 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +3,739 | $16.31 | $61K | 1,141,435 |
| 2017-01-09 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +35,360 | $16.31 | $577K | 9,497,239 |
| 2017-01-09 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +24,871 | $17.60 | $438K | 1,166,306 |
| 2017-01-09 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +235,169 | $17.60 | $4.1M | 9,732,408 |
| 2017-01-09 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +3,389 | $17.76 | $60K | 1,169,695 |
| 2017-01-09 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +32,051 | $17.76 | $569K | 9,764,459 |
| 2016-11-08 | Troupin Barbara Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2016-09-20 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +294,707 | $12.25 | $3.6M | 1,119,075 |
| 2016-09-20 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +2,476,348 | $12.25 | $30.3M | 9,404,467 |
| 2016-09-20 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +12,550 | $13.15 | $165K | 1,131,625 |
| 2016-08-03 | Jenkins Abigail Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2016-05-09 | Nolan Sean P. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2016-05-09 | Pelzer Robert Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2016-05-09 | SIMPSON TODD E Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2016-05-09 | LEVITT DANIEL J Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 |
Page 16 of 20 · 397 trades